Archive Newsletter
-
04.17.24 -- When Does GMP Matter In Non-GMP Settings?
4/17/2024
04/17/24 Cell & Gene Newsletter
-
04.16.24 -- Facing Purification Bottlenecks? Streamline Your DSP With Next-Gen Tools
4/16/2024
04/16/24 Cell & Gene Newsletter
-
04.16.24 -- Nanoscope Therapeutics Tackling Vision Loss With Ocular Gene Therapy
4/16/2024
04/16/24 Cell & Gene Newsletter
-
04.15.24 -- Shocking! Biotech Facilities Don't Maintain Themselves
4/15/2024
04/15/24 Cell & Gene Newsletter
-
04.11.24 -- Drugging The Undruggable: Strategies And Future Directions
4/11/2024
04/11/24 Cell & Gene Newsletter
-
04.10.24 -- Efficient Isolator Design, Cleanroom Selection Tips, and Decentralized Manufacturing Trends
4/10/2024
04/10/24 Cell & Gene Newsletter
-
04.10.24 -- How To Promote Batch-To-Batch Consistency In CAR-T Therapies
4/10/2024
04/10/24 Cell & Gene Newsletter
-
04.09.24 -- Getting T Cell Therapies To The Clinic
4/9/2024
04/09/24 Cell & Gene Newsletter
-
04.09.24 -- Reducing Toxicities In Allogeneic Cell Therapies
4/9/2024
04/09/24 Cell & Gene Newsletter
-
04.08.24 -- New Episodes: Allogeneic Cell Therapy Toxicities (and how to reduce them); Biotech and The Innovator's Dilemma.
4/8/2024
04/08/24 Cell & Gene Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more